ACM
Aster Capital Management Portfolio holdings
AUM
$441M
1-Year Return
16.94%
This Quarter Return
-2.84%
1 Year Return
+16.94%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$540M
AUM Growth
+$278M
(+106%)
Cap. Flow
+$276M
Cap. Flow
% of AUM
51.02%
Top 10 Holdings %
Top 10 Hldgs %
12.98%
Holding
1,752
New
676
Increased
379
Reduced
144
Closed
551
Top Buys
| 1 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$13.7M |
| 2 |
Amazon
AMZN
|
+$12.3M |
| 3 |
Eli Lilly
LLY
|
+$7.68M |
| 4 |
SPDR S&P Bank ETF
KBE
|
+$6.78M |
| 5 |
SPDR S&P Retail ETF
XRT
|
+$6.16M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
+$16.7M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$8.63M |
| 3 |
Mastercard
MA
|
+$4.98M |
| 4 |
Apple
AAPL
|
+$4.91M |
| 5 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$3.51M |
Sector Composition
| 1 | Technology | 13.35% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.19% |
| 5 | Healthcare | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Sabra Healthcare REIT
SBRA
$4.59B
| $33.1K | 0.01% |
+1,990
| New | +$33.1K |
|
902
Dynatrace
DT
$14.8B
| $33K | 0.01% |
577
+174
| +43% | +$9.96K |
|
903
Mirum Pharmaceuticals
MIRM
$3.82B
| $33K | 0.01% |
694
+610
| +726% | +$29K |
|
904
Apogee Therapeutics
APGE
$2.22B
| $33K | 0.01% |
1,050
+960
| +1,067% | +$30.2K |
|
905
Pathward Financial
CASH
$1.74B
| $32.7K | 0.01% |
+422
| New | +$32.7K |
|
906
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.52B
| $32.6K | 0.01% |
+1,136
| New | +$32.6K |
|
907
FIGS
FIGS
$1.19B
| $32.5K | 0.01% |
+7,104
| New | +$32.5K |
|
908
Disc Medicine
IRON
$2.1B
| $32.4K | 0.01% |
577
+523
| +969% | +$29.4K |
|
909
ARS Pharmaceuticals
SPRY
$1B
| $32.4K | 0.01% |
3,091
+2,483
| +408% | +$26K |
|
910
Churchill Downs
CHDN
$6.93B
| $32.2K | 0.01% |
+272
| New | +$32.2K |
|
911
Jefferies Financial Group
JEF
$13.9B
| $31.9K | 0.01% |
+482
| New | +$31.9K |
|
912
SFL Corp
SFL
$1.1B
| $31.9K | 0.01% |
3,531
+2,042
| +137% | +$18.4K |
|
913
Phreesia
PHR
$1.53B
| $30.9K | 0.01% |
+1,164
| New | +$30.9K |
|
914
The Greenbrier Companies
GBX
$1.46B
| $30.7K | 0.01% |
+547
| New | +$30.7K |
|
915
Dyne Therapeutics
DYN
$1.88B
| $30.7K | 0.01% |
2,252
+2,234
| +12,411% | +$30.4K |
|
916
Savers
SVV
$1.98B
| $30.6K | 0.01% |
4,090
+3,344
| +448% | +$25K |
|
917
Ultra Clean Holdings
UCTT
$1.16B
| $30.6K | 0.01% |
1,243
+1,225
| +6,806% | +$30.1K |
|
918
HealthEquity
HQY
$7.96B
| $30.5K | 0.01% |
+278
| New | +$30.5K |
|
|
NLOP
919
Net Lease Office Properties
NLOP
$432M
| $30.2K | 0.01% |
+930
| New | +$30.2K |
|
920
Celldex Therapeutics
CLDX
$1.67B
| $29.7K | 0.01% |
1,446
+1,256
| +661% | +$25.8K |
|
921
Franklin Covey
FC
$246M
| $29.7K | 0.01% |
+930
| New | +$29.7K |
|
922
Tactile Systems Technology
TCMD
$306M
| $29.6K | 0.01% |
+2,070
| New | +$29.6K |
|
923
Kiniksa Pharmaceuticals
KNSA
$2.74B
| $29.5K | 0.01% |
+1,456
| New | +$29.5K |
|
924
Willdan Group
WLDN
$1.55B
| $29.4K | 0.01% |
+900
| New | +$29.4K |
|
925
Skyward Specialty Insurance
SKWD
$1.93B
| $29.4K | 0.01% |
+565
| New | +$29.4K |
|